SOURCE: Arnold William Klein, MD

March 04, 2009 10:12 ET

UPDATE: World-Renown Dermatologist Prepares to Speak Outside of the Annual Meeting of the American Academy of Dermatology

LOS ANGELES, CA--(Marketwire - March 4, 2009) - The American Academy of Dermatology will be hosting its 67th Annual Meeting in San Francisco beginning on Thursday, March 5th. It's a six-day event offering an ever-evolving selection of courses, symposia, workshops, forums, discussion groups and focus sessions. It's considered one of the primary educational events of the academy, including courses that offer insight into legal and ethical issues. This year, however, the most important session on legal and ethical issues in dermatology will not be taking place within the walls of the academy but rather in the Paris Ballroom at Hotel Monaco in San Francisco on 501 Geary Street at Taylor.

On Friday, March 6th, starting at 6:30 PM, Dr. Arnold William Klein, the international authority on minimally invasive aesthetics and renowned for pioneering the cosmetic use of Botox and dermal fillers, will be conducting a discussion on legal and ethical issues in the field of aesthetics. Dr. Klein is a Professor of Medicine and Dermatology at the David Geffen School of Medicine at UCLA and an emeritus attending physician at the Cedars-Sinai Medical Center in Los Angeles. A prolific author, he has published nearly 150 scientific papers in prestigious peer-reviewed journals and has written four medical textbooks and numerous textbook chapters.

Recently, Dr. Klein took a stand against the industry and the Food and Drug Administration over a popular but potentially dangerous new injectable filler. "The purpose of the FDA is to protect the public interest in safety and efficacy of all medical products, drugs and devices," says Dr. Klein. "I am both alarmed and appalled by the FDA's approval of substances such as injectable Plexiglas (Artefill), ground-up suture material (Sculptra), and injectable bone (Radiesse). These compounds have severely scarred and impaired the health of people around the world, and as a result, are no longer used in most countries. What's even more shocking is the discovery that articles written about agents such as Botox are totally incorrect and rely on falsified data."

The FDA has over 180 reports of life-threatening adverse reactions to Botox with 80 requiring hospitalization. According to Dr. Klein, "Profit has replaced patient safety as the major theme of Continuing Medical Education courses, thus setting the stage for a potential medical disaster. Compounding this is the forged medical literature and illicit promotion of products to American physicians by unlicensed foreign physicians."

From his office on Roxbury Drive in Beverly Hills, Dr. Klein maintains a very busy, prestigious practice, catering to some of Hollywood's biggest stars. His expertise has garnered him recognition as the international father of architectural facial restoration, and the superior techniques he developed for natural-looking soft tissue augmentation are used around the world today. In the fields of dermatology and minimally invasive aesthetics, he is the best. But none of this changes the fact that he's become persona non-gratis at U.S. society meetings and speaking engagements. "I have voiced my serious concerns and raised questions about the alteration of data published in peer-reviewed journals, and as a result, I have been terminated from one manufacturer's advisory board and from the editorial board of a peer-reviewed publication," says Dr. Klein. "Maybe they don't want anyone to question how they are re-writing history or making a very useful toxin potentially dangerous. I, for one, will not be quiet. It's not enough to do no harm; one must do good."

Being a vocal advocate for patient safety is one of Dr. Klein's means to doing good, and the symposium scheduled is meant to educate fellow dermatologists. "The FDA, medical societies, continuing medical education organizations, and many physicians -- all of whom were once distinguishable entities -- have so enmeshed themselves with America's biggest pharmaceutical companies that it's all but impossible to see where one begins and the other ends. I want to see this stop." For Dr. Klein, offering his expertise and knowledge to fellow physicians is just one small step towards making this happen.

Contact Information

  • Contact:
    Fleur Henry
    Communications Director
    Arnold Klein, MD
    310.275.5136